Literature DB >> 20875486

Effectiveness of seasonal 2008-2009, 2009-2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellón, Spain. A test-negative, hospital-based, case-control study.

Joan Puig-Barberà1, Alberto Arnedo-Pena, Francisco Pardo-Serrano, María Dolores Tirado-Balaguer, Silvia Pérez-Vilar, Ester Silvestre-Silvestre, Consuelo Calvo-Mas, Lourdes Safont-Adsuara, Montserrat Ruiz-García.   

Abstract

We estimate the impact of the two previous influenza seasonal vaccines and the pandemic vaccine on risk of A (H1N1) 2009 laboratory confirmed hospitalizations during the autumn 2009 pandemic wave in Castellón, Spain. We conducted a test-negative, hospital-based, case-control study. Influenza A (H1N1) 2009 infection was detected in 147 (44%) of 334 patients hospitalized for a presumptive influenza related illness. No effect was observed for the 2008-2009 and 2009-2010 seasonal influenza vaccines. However, the pandemic vaccine was associated with an adjusted vaccine effectiveness of 90% (95% CI, 48-100%). Pandemic vaccines were effective in preventing pandemic influenza associated hospitalizations.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20875486     DOI: 10.1016/j.vaccine.2010.09.042

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  41 in total

1.  Pandemic and seasonal vaccine coverage and effectiveness during the 2009-2010 pandemic influenza in an Italian adult population.

Authors:  Simona Costanzo; Francesco Gianfagna; Mariarosaria Persichillo; Francesca De Lucia; Francesca D Lucia; Angelita Verna; Modjenar Djidingar; Sara Magnacca; Francesca Bracone; Marco Olivieri; Maria Benedetta Donati; Giovanni de Gaetano; Licia Iacoviello
Journal:  Int J Public Health       Date:  2012-02-28       Impact factor: 3.380

2.  The effectiveness of seasonal trivalent inactivated influenza vaccine in preventing laboratory confirmed influenza hospitalisations in Auckland, New Zealand in 2012.

Authors:  Nikki Turner; Nevil Pierse; Ange Bissielo; Q Sue Huang; Michael G Baker; Marc-Alain Widdowson; Heath Kelly
Journal:  Vaccine       Date:  2014-04-24       Impact factor: 3.641

3.  Effectiveness of an Indian-made attenuated influenza A(H1N1)pdm 2009 vaccine: a case control study.

Authors:  Prasad S Kulkarni; Sharad Agarkhedkar; Sanjay Lalwani; Ashish R Bavdekar; Sameer Jog; Sidram K Raut; Varsha Parulekar; Shalaka S Agarkhedkar; Sonali Palkar; Somnath Mangrule
Journal:  Hum Vaccin Immunother       Date:  2014-01-09       Impact factor: 3.452

4.  Seroprevalence of pandemic (H1N1) 2009 influenza and effectiveness of 2010/2011 influenza vaccine during 2010/2011 season in Beijing, China.

Authors:  Peng Yang; Li Zhang; Weixian Shi; Guilan Lu; Shujuan Cui; Xiaomin Peng; Daitao Zhang; Yimeng Liu; Huijie Liang; Xinghuo Pang; Quanyi Wang
Journal:  Influenza Other Respir Viruses       Date:  2011-12-30       Impact factor: 4.380

Review 5.  Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review.

Authors:  Sheena G Sullivan; Shuo Feng; Benjamin J Cowling
Journal:  Expert Rev Vaccines       Date:  2014-10-28       Impact factor: 5.217

6.  The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology.

Authors:  Huiying Chua; Shuo Feng; Joseph A Lewnard; Sheena G Sullivan; Christopher C Blyth; Marc Lipsitch; Benjamin J Cowling
Journal:  Epidemiology       Date:  2020-01       Impact factor: 4.822

Review 7.  Effectiveness of influenza vaccines in preventing severe influenza illness among adults: A systematic review and meta-analysis of test-negative design case-control studies.

Authors:  Marc Rondy; Nathalie El Omeiri; Mark G Thompson; Alain Levêque; Alain Moren; Sheena G Sullivan
Journal:  J Infect       Date:  2017-09-18       Impact factor: 6.072

Review 8.  Partial protection against 2009 pandemic influenza A (H1N1) of seasonal influenza vaccination and related regional factors: Updated systematic review and meta-analyses.

Authors:  Zhi-yuan Li; Jin-yan Chen; Yan-ling Zhang; Wei-ming Fu
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

9.  Pandemic influenza A(H1N1)pdm09: risk of infection in primary healthcare workers.

Authors:  Ben Hudson; Les Toop; Dee Mangin; Cheryl Brunton; Lance Jennings; Lynn Fletcher
Journal:  Br J Gen Pract       Date:  2013-06       Impact factor: 5.386

10.  Incorporating Real-time Influenza Detection Into the Test-negative Design for Estimating Influenza Vaccine Effectiveness: The Real-time Test-negative Design (rtTND).

Authors:  Leora R Feldstein; Wesley H Self; Jill M Ferdinands; Adrienne G Randolph; Michael Aboodi; Adrienne H Baughman; Samuel M Brown; Matthew C Exline; D Clark Files; Kevin Gibbs; Adit A Ginde; Michelle N Gong; Carlos G Grijalva; Natasha Halasa; Akram Khan; Christopher J Lindsell; Margaret Newhams; Ithan D Peltan; Matthew E Prekker; Todd W Rice; Nathan I Shapiro; Jay Steingrub; H Keipp Talbot; M Elizabeth Halloran; Manish Patel
Journal:  Clin Infect Dis       Date:  2021-05-04       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.